Segment Reporting (Tables)

12 Months Ended

Jun. 30, 2026

Statements [Line Items]

Disclosure of Operating Segment Information


Operating segment information June 30, 2026		Immunotherapy A$				Unallocated A$				Consolidated A$
Revenue
License revenue			14,556,923				—				14,556,923
Other income
Research material sales			38,607				—				38,607
Grant income			5,338,572				—				5,338,572
Miscellaneous income			—				—				—
Net gain on foreign exchange			—				1,229,851				1,229,851
Interest income			—				3,005,047				3,005,047

Total revenue and other income			19,934,102				4,234,898				24,169,000

Result
Segment Result			(81,592,146	)			2,287,583				(79,304,563	)
Profit/(loss) before income tax expense			(81,592,146	)			2,287,583				(79,304,563	)
Income tax expense			—				—				—
Loss after income tax expense											(79,304,563	)

Total segment assets			83,267,229				—				83,267,229

Total segment liabilities			21,734,183				—				21,734,183


Operating segment information June 30, 2025		Immunotherapy A$				Unallocated A$				Consolidated A$
Revenue
License revenue			—				—				—
Other income
Research material sales			59,709				—				59,709
Grant income			4,974,823				—				4,974,823
Miscellaneous income			—				390				390
Net change on fair value movement			—				9,242				9,242
Interest income			—				5,287,209				5,287,209

Total revenue and other income			5,034,532				5,296,841				10,331,373

Result
Segment Result			(65,020,504	)			3,586,339				(61,434,165	)
Profit/(loss) before income tax expense			(65,020,504	)			3,586,339				(61,434,165	)
Income tax expense			—				—				—
Loss after income tax expense											(61,434,165	)

Total segment assets			156,983,434				—				156,983,434

Total segment liabilities			13,348,071				—				13,348,071


Operating segment information June 30, 2024		Immunotherapy A$				Unallocated A$				Consolidated A$
Revenue
License revenue			—				—				—
Other income
Research material sales			119,089				—				119,089
Grant income			3,722,788				—				3,722,788
Net gain on foreign exchange			—				113,458				113,458
Interest income			—				3,882,757				3,882,757

Total revenue and other income			3,841,877				3,996,215				7,838,092

Result
Segment Result			(46,556,929	)			3,840,304				(42,716,625	)
Profit/(loss) before income tax expense			(46,556,929	)			3,840,304				(42,716,625	)
Income tax expense			—				—				—
Loss after income tax expense											(42,716,625	)

Total segment assets			201,579,281				—				201,579,281

Total segment liabilities			12,057,539				—				12,057,539